Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Technology Landscape, Trends and Stent Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The technologies in stent have undergone significant change in recent years, with bare metal coronary stents to bioabsorbable stents. The rising wave of new technologies such as drug-eluting stents (DES) and bioabsorbable stents technology are creating significant potential for advanced stent implants in various medical platforms due to increasing adoption of minimally invasive techniques.

In stent market, various technologies such as drug-eluting stents (DES), bare-metal coronary stents, and bioabsorbable stents, iliac stents, femoral-popliteal stents, renal and related stents, and carotid stents are used in the coronary and peripheral vascular applications. Increasing adoption of minimally invasive techniques, rising number of cardiovascular surgeries, and hectic lifestyle coupled with rising geriatric population base are creating opportunities for various stent technologies.
Some of the latest technological developments by various countries in the stent market are as follows:
  • United States: Abbott announced FDA approval of the Absorb bioresorbable stent for treating peripheral artery disease (PAD) in the leg. This minimally invasive stent dissolves after opening the blocked artery, potentially reducing long-term complications.
  • Europe: Boston Scientific received CE Mark approval for its new Orca DES with a thinner profile designed for easier access to smaller vessels. This caters to the growing demand for minimally invasive procedures in Europe. The French government launched an initiative to promote the use of DES with lower drug doses, aiming to reduce potential side effects while maintaining efficacy.
  • China: Several Chinese med-tech companies are focusing on developing stents with innovative biocompatible coatings to improve long-term patency and reduce inflammation. These advancements aim to address the growing demand for efficient stents in China's large patient population.
  • India: Trivitron Healthcare is increasing production of BMS to meet the need for affordable stent options in the country. Government price caps on DES have driven this trend, making BMS a more attractive option for cost-conscious patients.
This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the stent market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.


Stent Technology Market


Stent Technology Market Segments

Stent Technology Heat Map
                                    

The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global stent technology by application, technology, and region as follows:

Technology Readiness by Technology Type

Competitive Intensity and Regulatory Compliance

Disruption Potential by Technology Type

Trends and Forecasts by Technology Type [$M shipment analysis from 2018 to 2030]:
  • Drug-Eluting Stents (DES)
  • Bare-Metal Coronary Stents
  • Bioabsorbable Stents
  • Iliac Stents
  • Femoral-Popliteal Stents
  • Renal and Related Stents
  • Carotid Stents

Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:
  • Coronary
    • Drug-Eluting Stents (DES)
    • Bare-Metal Coronary Stents
    • Bioabsorbable Stents
  • Peripheral Vascular
    • Iliac Stents
    • Femoral-Popliteal Stents
    • Renal and Related Stents
    • Carotid Stents

Technology Trends and Forecasts by Region [$M shipment analysis for 2018 – 2030]:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • South Korea
    • India
  • The Rest of the World

Latest Developments and Innovations in the Stent Technologies

Companies / Ecosystems

Strategic Opportunities by Technology Type

Some of the stent companies profiled in this report include Terumo Corporation, Stentys, Microport Scientific Corporation, Medtronic, Elixir Medical Corporation, C. R. Bard, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen, and Abbott Laboratories.
Below are the latest technological developments from top companies in the stent market:
  • Abbott Laboratories received FDA approval for the new Xience Xpedient DES with a thinner profile for wider applicability in patients.
  • Boston Scientific Corporation announced plans to expand its DES manufacturing capacity in Asia to meet growing demand.
  • Medtronic plc partnered with a leading biomaterial company to develop next-generation DES with improved drug delivery capabilities.
  • Biotronik SE & Co. KG launched its new low-profile BMS specifically designed for treating complex coronary artery lesions.
  • Teleflex Incorporated completed the acquisition of a smaller competitor, gaining a foothold in the BMS market.
  • Integer Holdings Corporation announced a significant investment to upgrade its manufacturing facilities for BMS components.
  • Amgen Inc. partnered with a medical device company to co-develop a bioabsorbable stent that dissolves after the artery heals.
  • Boston Scientific Corporation received CE Mark approval for its next-generation bioabsorbable stent platform in Europe.
  • Cardiovascular Systems Inc. announced positive clinical trial results for its bioabsorbable stent, targeting FDA approval in the near future.
This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the stent market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in stent market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in stent market?
Q.6 What are the latest developments in stent technologies? Which companies are leading these developments? 
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this stent market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this stent technology space?
Table of Contents

1. Executive Summary

2. Technology Landscape
2.1. Technology Background and Evolution
2.2. Technology and Application Mapping
2.3. Supply Chain

3. Technology Readiness
3.1. Technology Commercialization and Readiness
3.2. Drivers and Challenges in Stent Technologies
3.3. Competitive Intensity
3.4. Regulatory Compliance

4. Technology Trends and Forecasts Analysis from 2018-2030
4.1. Stent Opportunity
4.2. Technology Trends (2018-2023) and Forecasts (2024-2030)
4.2.1. Drug-Eluting Stents (DES)
4.2.2. Bare-Metal Coronary Stents
4.2.3. Bioabsorbable Stents
4.2.4. Iliac Stents
4.2.5. Femoral-Popliteal Stents
4.2.6. Renal and Related Stents
4.2.7. Carotid Stents
4.3. Technology Trends (2018-2023) and Forecasts (2024-2030) by Application Segments
4.3.1. Coronary Stent
4.3.1.1. Drug-Eluting Stents (DES)
4.3.1.2. Bare-Metal Coronary Stents
4.3.1.3. Bioabsorbable Stents
4.3.2. Peripheral Vascular
4.3.2.1. Iliac Stents
4.3.2.2. Femoral-Popliteal Stents
4.3.2.3. Renal and Related Stents
4.3.2.4. Carotid Stents

5. Technology Opportunities (2018-2030) by Region
5.1. Stent Market by Region
5.2. North American Stent Technology Market
5.2.1. United States Stent Technology Market
5.2.2. Canadian Stent Technology Market
5.2.3. Mexican Stent Technology Market
5.3. European Stent Technology Market
5.3.1. The United Kingdom Stent Technology Market
5.3.2. German Automotive Stent Technology Market
5.3.3. French Automotive Stent Technology Market
5.4. APAC  Stent Technology Market
5.4.1. Chinese Stent System Technology Market
5.4.2. Japanese Stent System Technology Market
5.4.3. Indian Stent System Technology Market
5.4.4. South Korean Stent Technology Market
5.5. ROW Stent Technology Market

6. Latest Developments and Innovations in the Stent Technologies

7. Companies / Ecosystem
7.1. Product Portfolio Analysis
7.2. Market Share Analysis
7.3. Geographical Reach

8. Strategic Implications
8.1. Implications
8.2. Growth Opportunity Analysis
8.2.1. Growth Opportunities for the Stent Market by Technology Type
8.2.2. Growth Opportunities for the Stent Market by Application
8.2.3. Growth Opportunities for the Stent Market by Region
8.3. Emerging Trends in the Stent Market
8.4. Disruption Potential
8.5. Strategic Analysis
8.5.1. New Product Development
8.5.2. Capacity Expansion of the Stent Market
8.5.3. Mergers, Acquisitions, and Joint Ventures in the Stent Market

9. Company Profiles of Leading Players
9.1. Terumo Corporation
9.2. Stentys
9.3. Microport Scientific Corporation
9.4. Medtronic
9.5. Elixir Medical Corporation
9.6. C. R. Bard
9.7. Boston Scientific Corporation
9.8. Biotronik SE & Co. KG
9.9. B. Braun Melsungen
9.10. Abbott Laboratories
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Technology Landscape, Trends and Opportunities in the Global Stent Market Full Report $ 4,850
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Technology Landscape, Trends and Opportunities in the Global Stent Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on